Browsing by Author "Paredes, Roger"
Now showing items 1-3 of 3
-
Computational Prediction of HIV-1 Resistance to Protease Inhibitors
Hosseini, Ali; Alibés, Andreu; Noguera-Julian, Marc; Gil, Victor; Paredes, Roger; Soliva, Robert; Orozco, Modesto; Guallar, Víctor (American Chemical Society, 2016-04-15)
Article
Open AccessDevelopment of mutations in HIV-1 PR hinders the activity of antiretroviral drugs, forcing changes in drug prescription. Most resistance assessments used to date rely on expert-based rules on predefined sets of stereotypical ... -
Increased peripheral proinflammatory cytokines in HIV-1-infected patients with prolonged viral suppression suffering from high psychological stress
Clotet, Bonaventura; Fernández Castro, Jordi; Fumaz, Carmina R.; Gonzalez Garcia, Marian; Borràs, Xavier; Muñoz Moreno, Jose A.; Peña, Ruth; Pérez Álvarez, Nuria; Puig, Jordi; Paredes, Roger (2009-11)
Article
Restricted access - publisher's policy"In summary, patients who reported high levels of stress had significantly higher levels of peripheral proinflammatory cytokines, especially IL-6. The levels in our patients who reported stress averaged more than 6 times ... -
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study
Echeverria, Patricia; Bonjoch, Anna; Puig Batalla, Jorge; Molto, Jose; Paredes, Roger; Sirera, Guillem; Ornelas, Arelly; Pérez Álvarez, Nuria; Clotet, Bonaventura; Negredo, Eugènia (2014-02-04)
Article
Open AccessBackground: Etravirine (ETR) was approved for patients with virological failure and antiretroviral resistance mutations. It has also shown antiviral efficacy in antiretroviral-naive patients. However, data on the switching ...